| 000 | 00996 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513191949.0 | ||
| 264 | 0 | _c19991014 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.319.7210.643c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcKibbin, M | |
| 245 | 0 | 0 |
_aEarly trials of angiogenic factors have not targeted patients most at risk of ocular disease. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cSep 1999 |
||
| 300 |
_a643-4 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aEye Diseases _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIschemia _xpathology |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xpathology |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xetiology |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aO'Neill, D | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 319 _gno. 7210 _gp. 643-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.319.7210.643c _zAvailable from publisher's website |
| 999 |
_c10430995 _d10430995 |
||